Grantham, Mayo, Van Otterloo & Co (GMO)
MDT icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Medtronic MDT Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.91M Sell
33,553
-10,987
-25% -$1.05M 0.01% 394
2025
Q4 		$4.28M Sell
44,540
-6,576
-13% -$639K 0.01% 331
2025
Q3 		$4.87M Sell
51,116
-16,507
-24% -$1.52M 0.01% 295
2025
Q2 		$5.89M Sell
67,623
-101,319
-60% -$8.59M 0.02% 274
2025
Q1 		$15.2M Sell
168,942
-46,433
-22% -$4.15M 0.05% 205
2024
Q4 		$17.2M Buy
215,375
+9,646
+5% +$835K 0.06% 201
2024
Q3 		$18.5M Sell
205,729
-1,761
-0.8% -$148K 0.06% 205
2024
Q2 		$16.3M Buy
207,490
+20,712
+11% +$1.7M 0.06% 221
2024
Q1 		$16.3M Buy
186,778
+36,507
+24% +$3.12M 0.06% 212
2023
Q4 		$12.4M Buy
150,271
+117,598
+360% +$8.96M 0.05% 224
2023
Q3 		$2.56M Sell
32,673
-56,673
-63% -$4.74M 0.01% 384
2023
Q2 		$7.87M Sell
89,346
-2,762,941
-97% -$238M 0.04% 282
2023
Q1 		$230M Sell
2,852,287
-13,654
-0.5% -$1.11M 1.17% 24
2022
Q4 		$223M Sell
2,865,941
-112,811
-4% -$9.14M 1.19% 23
2022
Q3 		$241M Sell
2,978,752
-10,812
-0.4% -$972K 1.39% 18
2022
Q2 		$268M Sell
2,989,564
-121,853
-4% -$12.3M 1.45% 16
2022
Q1 		$345M Sell
3,111,417
-7,732
-0.2% -$817K 1.67% 14
2021
Q4 		$323M Sell
3,119,149
-4,332
-0.1% -$502K 1.55% 17
2021
Q3 		$392M Buy
3,123,481
+142,443
+5% +$18.4M 1.94% 14
2021
Q2 		$370M Sell
2,981,038
-326
-0% -$40.9K 1.85% 14
2021
Q1 		$352M Sell
2,981,364
-32,127
-1% -$3.77M 1.92% 15
2020
Q4 		$353M Sell
3,013,491
-169,212
-5% -$18.6M 2.17% 10
2020
Q3 		$331M Sell
3,182,703
-64,931
-2% -$6.52M 2.35% 10
2020
Q2 		$298M Buy
3,247,634
+1,264
+0% +$121K 2.21% 10
2020
Q1 		$293M Sell
3,246,370
-52,341
-2% -$5.57M 2.44% 7
2019
Q4 		$374M Sell
3,298,711
-25,173
-0.8% -$2.76M 2.5% 7
2019
Q3 		$361M Buy
3,323,884
+12,603
+0.4% +$1.31M 2.5% 4
2019
Q2 		$322M Sell
3,311,281
-292,488
-8% -$26.7M 2.27% 5
2019
Q1 		$328M Sell
3,603,769
-23,427
-0.6% -$2.1M 2.36% 6
2018
Q4 		$330M Buy
3,627,196
+146,896
+4% +$13.7M 2.63% 6
2018
Q3 		$342M Sell
3,480,300
-88,227
-2% -$8.16M 2.32% 9
2018
Q2 		$306M Sell
3,568,527
-878,183
-20% -$73.4M 2.17% 8
2018
Q1 		$357M Buy
4,446,710
+365,699
+9% +$30.2M 2.18% 8
2017
Q4 		$330M Buy
4,081,011
+5,531
+0.1% +$443K 1.94% 11
2017
Q3 		$317M Sell
4,075,480
-297,364
-7% -$24.7M 1.85% 13
2017
Q2 		$388M Buy
4,372,844
+167,133
+4% +$14.1M 2.14% 10
2017
Q1 		$339M Sell
4,205,711
-103,859
-2% -$8.11M 1.91% 13
2016
Q4 		$307M Sell
4,309,570
-283,430
-6% -$22.3M 1.65% 15
2016
Q3 		$397M Buy
4,593,000
+148,176
+3% +$12.9M 1.87% 14
2016
Q2 		$386M Buy
4,444,824
+738,166
+20% +$59.7M 1.58% 15
2016
Q1 		$278M Sell
3,706,658
-838,882
-18% -$63.2M 1.04% 26
2015
Q4 		$350M Sell
4,545,540
-2,651,732
-37% -$200M 1.26% 21
2015
Q3 		$482M Sell
7,197,272
-348,342
-5% -$25.7M 1.67% 18
2015
Q2 		$559M Buy
7,545,614
+142,938
+2% +$10.9M 1.8% 17
2015
Q1 		$577M Buy
7,402,676
+7,398,630
+182,863% +$561M 1.72% 16
2014
Q4 		$292K Sell
4,046
-546,961
-99% -$38M ﹤0.01% 409
2014
Q3 		$34.1M Sell
551,007
-4,967,119
-90% -$316M 0.09% 113
2014
Q2 		$352M Sell
5,518,126
-1,532,333
-22% -$93.1M 0.96% 26
2014
Q1 		$434M Sell
7,050,459
-3,135,906
-31% -$183M 1.13% 23
2013
Q4 		$585M Buy
10,186,365
+62,283
+0.6% +$3.53M 1.42% 21
2013
Q3 		$539M Buy
10,124,082
+480,764
+5% +$25.9M 1.42% 19
2013
Q2 		$496M Buy
+9,643,318
New +$477M 1.29% 24

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s MDT Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Medtronic (MDT) stake by 25% in Q1 2026, selling an estimated $1.05M and leaving 33,553 shares worth $2.91M. The position accounts for 0.01% of the portfolio, ranked #394.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $585M in Q4 2013. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 33,553 shares of Medtronic worth $2.91M as of Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 10,987 Medtronic shares in Q1 2026, an estimated $1.05M.
  • Medtronic made up 0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #394 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Medtronic position peaked at $585M in Q4 2013.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.